IPNews® – Purdue Pharmaceuticals LP’s patent infringement claims against KVK Tech Inc. for preparing an abbreviated new drug application for a generic version of Purdue’s blockbuster painkiller OxyContin will go forward, a New York federal judge ruled Friday.
KVK had argued that although it did all the necessary work to come up with the generic